memoria2015

1 Introduction
8
Phase II trials currently represent almost 31% of the studies
developed at the Institute.
The present report also shows data reflecting the commitment
of INCLIVA to training and transfer of biomedical research. The
involvement of university research groups has resulted in high
participation in graduate programmes, generating 45 doctoral
theses this year. Regarding innovation and transfer activities it is
noteworthy that INCLIVA joint the Patents Bank, a joint program
of the Valencian Regional Government and public research
organizations to promote meetings between entrepreneurs,
businessmen and innovation knowledge centers, in order
to facilitate technological transfer to business. Moreover,
the institute was awarded by a grant for the first FIPSE call
for feasibility studies of health innovation. Finally, INCLIVA’s
innovation pipeline comprised, in 2015, 2 granted patents, 3
patent international extensions and 2 software records.
Among the activities to promote research culture, during
2015 INCLIVA continued with its Training Plan by collaborating
with the different hospital departments in the organization and
management of 62 training initiatives, including 15 courses, 8
workshops and 9 seminars and 30 conferences. In addition, as
every year the Institute provided grants for research secondments
in centers of excellence, that allowed 17 INCLIVA’s researchers to
acquire new knowledge in clinical and research.
We cannot conclude without expressing our gratitude to all
the professionals who enable INCLIVA to continue advancing.
Thanks to the efforts of our over 500 researchers, 180 of which
are directly hired by the Foundation, INCLIVA is able to maintain
its present privileged position. However, all at INCLIVA face
the challenge of continuing to generate scientific knowledge,
guiding research excellence for the benefit of society and being
an important part of solidarity initiatives.
Rafael Carmena Rodríguez
General Director
Josep Redón i Mas
Scientific Director